美聯新材(300586.SZ)擬設立順德分公司
格隆匯 7 月 8日丨美聯新材(300586.SZ)公佈,公司於2020年7月8日召開了第三屆董事會第二十二次會議,會議審議通過了《關於設立順德分公司的議案》,同意公司為滿足戰略佈局及業務發展需要在順德設立分公司。
分公司名稱:廣東美聯新材料股份有限公司順德分公司,經營範圍:研發、加工:色母粒、塑料改性、塑料新材料及技術服務。(依法須經批准的項目,經相關部門批准後方可開展經營活動。)
此次設立順德分公司,有利於拓展公司色母粒業務,提高公司的經營業績,進一步提升公司的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.